1. Home
  2. LGND vs AIN Comparison

LGND vs AIN Comparison

Compare LGND & AIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • AIN
  • Stock Information
  • Founded
  • LGND 1987
  • AIN 1895
  • Country
  • LGND United States
  • AIN United States
  • Employees
  • LGND N/A
  • AIN N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • AIN Textiles
  • Sector
  • LGND Health Care
  • AIN Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • AIN Nasdaq
  • Market Cap
  • LGND 2.0B
  • AIN 1.9B
  • IPO Year
  • LGND 1992
  • AIN 1987
  • Fundamental
  • Price
  • LGND $114.07
  • AIN $67.91
  • Analyst Decision
  • LGND Strong Buy
  • AIN Buy
  • Analyst Count
  • LGND 8
  • AIN 5
  • Target Price
  • LGND $144.71
  • AIN $79.00
  • AVG Volume (30 Days)
  • LGND 116.0K
  • AIN 249.1K
  • Earning Date
  • LGND 08-05-2025
  • AIN 08-05-2025
  • Dividend Yield
  • LGND N/A
  • AIN 1.60%
  • EPS Growth
  • LGND N/A
  • AIN N/A
  • EPS
  • LGND N/A
  • AIN 2.49
  • Revenue
  • LGND $181,488,000.00
  • AIN $1,206,059,000.00
  • Revenue This Year
  • LGND $18.41
  • AIN $0.19
  • Revenue Next Year
  • LGND $18.87
  • AIN $4.14
  • P/E Ratio
  • LGND N/A
  • AIN $27.16
  • Revenue Growth
  • LGND 53.40
  • AIN 1.17
  • 52 Week Low
  • LGND $77.53
  • AIN $57.71
  • 52 Week High
  • LGND $129.90
  • AIN $95.47
  • Technical
  • Relative Strength Index (RSI)
  • LGND 62.44
  • AIN 53.16
  • Support Level
  • LGND $111.88
  • AIN $67.33
  • Resistance Level
  • LGND $116.16
  • AIN $69.14
  • Average True Range (ATR)
  • LGND 3.58
  • AIN 1.22
  • MACD
  • LGND 0.89
  • AIN 0.05
  • Stochastic Oscillator
  • LGND 85.19
  • AIN 73.50

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About AIN Albany International Corporation

Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.

Share on Social Networks: